Polaris Strategic Partners United States

An innovative company to partner with emerging biotech companies in drug clinical development and commercialization through United States and China alliance of drug development.
Jane Fang
CEO 

Prinston Pharma United States

Huahai Pharmaceutical
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Business Development
Headquartner in China
Mr. Yingming Yue
VP, operations 
Functionality

Privity FZ LLE United Arab Emirates

About Privity
Privity was founded in 2004, an independent Venture-focused advisory firm that seeks entrepreneurs with interesting and unique ideas and helps them develop and grow. Privity is agnostic to geography and industry vertical. It focuses on the quality of the entrepreneur and the compelling value proposition of the idea.
Company Size (Fulltime employees)
Year of foundation
2004
Please specify your partnering goal
Trustworthy
Headquartner in China
Mr. Sleem Hasan
Founder & CEO 

probevccapitcal China

no
Website:
no
Partnering Objectives
Headquartner in China
鑫 黄
投资经理 

Product Creation Studio United States

PCS provides new product engineering and design services for medical device and Medtech companies. We have served enterprise and entrepreneurs for over two decades and our QMS is ISO13485:2016 certified.
Company Size (Fulltime employees)
Year of foundation
21
Please specify your partnering goal
Provide high-end medical device design capabilities to Chinese healthcare companies.
Headquartner in China
Target client type
Companies in need of custom medical devices, drug delivery solutions, diagnostics or research tools
Dr. Scott Thielman
CTO 
Functionality

Protheragen Inc. United States

Protheragen’s business is growing rapidly after founded in Ronkonkoma, New York in 2009. More offices have been established at different locations across China and the US ever since. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.

To continue our development, part of our strategies requires us to constantly seeking high-quality novel drug research and development programs that are open to collaboration opportunities. Relying on strong industry resources and connections built up throughout the years, we welcome partnerships in the following structures: equity investment, intermediary service and project incubation.
Company Size (Fulltime employees)
Please specify your partnering goal
equity investment and program incubation
Headquartner in China
Dr. Donghai Chen
Business Development Director 

Proxima Ventures China

Healthcare VC
Partnering Objectives
Headquartner in China
Xiaolu Sun
Founder